Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating activated lymphocyte subsets as potential blood biomarkers of cancer progression

27 May 2020

Abstract excerpt

Abstract The objective of this study was to predict the value of lymphocyte subsets in cancer progression. Peripheral blood was obtained from 327 untreated patients with cancer and 158 healthy volunteers. Levels of lymphocyte subsets were determined by flow cytometry. There were decreased levels of natural killer (NK) cells, CD8+ T cells, and naïve CD4+/CD4+ T cells in untreated patients with cancer compared to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immune Cell Function and Interaction
Share to Immune cells in cancer
Share to Inflammatory Biomarkers in Disease Prognosis

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32459060
DOI: 10.1002/cam4.3150

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 24 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating activated lymphocyte subsets as potential blood biomarkers of cancer progressionPMID 32459060Read ↗

Characterization and predictive value of lymphocyte subsets in peripheral blood of patients with colorectal cancerSemantic proximity Read ↗

Natural killer cell subsets and their functional molecules in peripheral blood of the patients with breast cancerSemantic proximity Read ↗

Association of Lymphocyte Subsets in Advanced Non-Small Cell Lung Cancer Patients with the Efficacy and Prognosis of Immune Checkpoint Inhibitor Therapy: A Retrospective StudySemantic proximity Read ↗

T lymphocyte subsets in cancer immunity: Friends or foesSemantic proximity Read ↗

Identification of the NKG2D haplotypes associated with natural cytotoxic activity of peripheral blood lymphocytes and cancer immunosurveillance.Semantic proximity Read ↗

Phenotypic and functional exhaustion of circulating CD3+ CD56+ NKT-like cells in colorectal cancer patients.Semantic proximity Read ↗

The profile and prognostic value of circulating lymphocyte subsets in metastatic colon cancer.Semantic proximity Read ↗

[Cytotoxic T lymphocytes in peripheral blood and regional lymph nodes in laryngeal cancer patients].Semantic proximity Read ↗

Identification of Anti-tumor Cells Carrying Natural Killer (NK) Cell Antigens in Patients With Hematological Cancers.Semantic proximity Read ↗

Th2 subset dominance among peripheral blood T lymphocytes in patients with digestive cancersSemantic proximity Read ↗

Accumulation of circulating myeloid-derived suppressor cell subsets: predicting poor clinical efficacy and prognosis through T cell suppression in non-Hodgkin's lymphomaSemantic proximity Read ↗

The prognostic role of circulating CD8+ T cell proliferation in patients with untreated extensive stage small cell lung cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.